Press Release

Reproductive Genetics Market to be dominated by Microarray type through 2028

Increasing demand for genetic testing and screening is expected to drive the growth of global reproductive genetics market in the forecast period, 2024-2028.

According to TechSci Research report, Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, the global reproductive genetics market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing demand for genetic testing and screening to identify genetic disorders among the global population. Additionally, growing maternal age leading to pregnancy complications, especially in the developed countries in the North America and Europe, is expected to create lucrative opportunities for the market growth in the coming years. Besides, increasing demand for early detection and prevention of genetic disorder is further expected to support the market growth. Similarly, rising maternal age leads to pregnancy complications, and rising emphasis on early detection and prevention will further boost the market growth during the forecast period. Also, rising funding opportunities for testing instruments, shifting of reimbursement policies toward enhanced genetic testing coverage will drive the market growth over the years.

However, the lack of awareness on genetic disorders and high cost of genetic testing is slowing down the growth of global reproductive genetics market in the forecast period. Similarly, low economical conditions in the underdeveloped regions along with the lack of favorable insurance systems, may hamper the reproductive genetics market growth during the forecast period. Also, lack of social acceptance due to negative impacts of genetic testing in emerging countries, can further restrict the growth of global reproductive genetics market. Similarly, lack of regulations about genetic testing may hamper the growth of the market.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Reproductive Genetics Market".

Based on Technology, the global reproductive genetics market can be segmented into Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Microarrays. The microarray segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to identify structural abnormalities that are examined by ultrasonography on a pregnant woman and increasing number of pregnant women to gain insights into the prospects of having children and possibilities of genetic disorders.

Based on procedure type, the market can be segmented Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, and Infertility Genetic Testing. The carrier screening segment is expected to dominate during the forecast period on account of increasing demand to identifying genetic disorders such as down syndrome and reduce the risk of transferring it to their children. Also, growing advancements in genomic technologies and implementation of these technologies in clinical medicine have expanded the usage in the diagnosis of genetic disorders, carrier screening, and identification of causes of infertility this in turn is expected to create a significant growth of the market over the years.

Major companies operating in the global reproductive genetics market are:

  • CooperSurgical, Inc.
  • Centogene AG
  • Invitae Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc.,
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • Natera, Inc
  • Eurofins Scientific SE

In March 2020, Agilent Technology announced the launch of three new microarrays for prenatal and postnatal research. The microarray includes updated clinically relevant content from respected databases. Progression of next-generation sequencing is uncovering new gene-disease associations and databases are rapidly evolving to include these discoveries.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America is expected to dominate in the global reproductive genetics market due to the increasing number of invitro fertilization procedures among people across the region. Furthermore, the increasing adoption of advance genomic techniques to identify genetic disorders, along with the increasing demand for using advanced techniques in developing regions are further contributing to demand for reproductive genetics. Also, growing demand for needful information about the probability of having a child or not will further boost the market growth during the forecast period. Besides, increasing favorable government reimbursement policies and growing awareness about genome sequencing in the region are further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays), By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing), By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others), By Region and Competition”, has evaluated the future growth potential of global reproductive genetics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global reproductive genetics market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Connect with us on Twitter - https://twitter.com/TechSciResearch

Connect with us on LinkedIn - https://www.linkedin.com/company/techsci-research

Relevant News